Wegovy
- All
- News
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
- Saturday January 24, 2026
- Health | Written by Debosmita Ghosh
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
www.ndtv.com
-
Weight Loss Pill Wegovy Now Available On Amazon Pharmacy In The U.S.
- Sunday January 11, 2026
- Health | Written by Tanushka Dutta
Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical therapy from consumer health products.
-
www.ndtv.com
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
- Tuesday December 23, 2025
- Health | Written by Shreya Goswami
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
www.ndtv.com
-
Popular Weight-Loss Drugs Like Wegovy Fail To Lower Obesity-Related Cancer Risks, Study Finds
- Tuesday December 16, 2025
- Health | Written by Debosmita Ghosh
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type 2 diabetes, overweight, or obesity. These studies involved a total of more than 94,000 participants.
-
www.ndtv.com
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
- Sunday December 14, 2025
- Health | Written by Tanushka Dutta
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
www.ndtv.com
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
www.ndtv.com
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
- Friday December 12, 2025
- Health | Written by Debosmita Ghosh
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
www.ndtv.com
-
"Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research
- Wednesday October 8, 2025
- Health | Edited by NDTV News Desk
GLP-1 medications, Ozempic and Wegovy, may disrupt cancer imaging and its diagnosis, new research has revealed.
-
www.ndtv.com
-
Ozempic Launched In India: 14 Facts About The Diabetes, Weight Loss Drug
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been launched in India for type 2 diabetes.
-
www.ndtv.com
-
Ozempic Cleared For Use In India: Pros, Cons And Prices
- Friday December 12, 2025
- Health | Reported by Tanushka Dutta
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
www.ndtv.com
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
- Wednesday September 10, 2025
- Health | Written by Shreya Goswami
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
www.ndtv.com
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
- Sunday July 27, 2025
- Science | Edited by Ritu Singh
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
www.ndtv.com
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
- Tuesday July 8, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
www.ndtv.com/lifestyle
-
Novo Nordisk Launches Weight-Loss Drug 'Wegovy' In India
- Tuesday June 24, 2025
- India News | Reuters
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy as a once-a-week injection in India.
-
www.ndtv.com
-
UK Warns Women About 'Skinny Jabs' If Trying To Get Pregnant
- Thursday June 5, 2025
- World News | Agence France-Presse
The UK's medicine regulator warned on Thursday against taking "skinny jabs" for weight loss if trying to get pregnant or while breastfeeding because of their unknown effects on babies.
-
www.ndtv.com
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
- Saturday January 24, 2026
- Health | Written by Debosmita Ghosh
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
www.ndtv.com
-
Weight Loss Pill Wegovy Now Available On Amazon Pharmacy In The U.S.
- Sunday January 11, 2026
- Health | Written by Tanushka Dutta
Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical therapy from consumer health products.
-
www.ndtv.com
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
- Tuesday December 23, 2025
- Health | Written by Shreya Goswami
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
www.ndtv.com
-
Popular Weight-Loss Drugs Like Wegovy Fail To Lower Obesity-Related Cancer Risks, Study Finds
- Tuesday December 16, 2025
- Health | Written by Debosmita Ghosh
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type 2 diabetes, overweight, or obesity. These studies involved a total of more than 94,000 participants.
-
www.ndtv.com
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
- Sunday December 14, 2025
- Health | Written by Tanushka Dutta
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
www.ndtv.com
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
www.ndtv.com
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
- Friday December 12, 2025
- Health | Written by Debosmita Ghosh
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
www.ndtv.com
-
"Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research
- Wednesday October 8, 2025
- Health | Edited by NDTV News Desk
GLP-1 medications, Ozempic and Wegovy, may disrupt cancer imaging and its diagnosis, new research has revealed.
-
www.ndtv.com
-
Ozempic Launched In India: 14 Facts About The Diabetes, Weight Loss Drug
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been launched in India for type 2 diabetes.
-
www.ndtv.com
-
Ozempic Cleared For Use In India: Pros, Cons And Prices
- Friday December 12, 2025
- Health | Reported by Tanushka Dutta
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
www.ndtv.com
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
- Wednesday September 10, 2025
- Health | Written by Shreya Goswami
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
www.ndtv.com
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
- Sunday July 27, 2025
- Science | Edited by Ritu Singh
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
www.ndtv.com
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
- Tuesday July 8, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
www.ndtv.com/lifestyle
-
Novo Nordisk Launches Weight-Loss Drug 'Wegovy' In India
- Tuesday June 24, 2025
- India News | Reuters
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy as a once-a-week injection in India.
-
www.ndtv.com
-
UK Warns Women About 'Skinny Jabs' If Trying To Get Pregnant
- Thursday June 5, 2025
- World News | Agence France-Presse
The UK's medicine regulator warned on Thursday against taking "skinny jabs" for weight loss if trying to get pregnant or while breastfeeding because of their unknown effects on babies.
-
www.ndtv.com